Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report
DOI:
https://doi.org/10.48208/HeadacheMed.2020.19Palavras-chave:
Pseudotumor Cerebri, Intracranial Hypertension, Hypoparathyroidism, Fahr's syndrome, Headache, Idiopathic intracranial hypertensionResumo
Introduction Headaches are extremely common complications in emergency departments, accounting for up to 16% of visits, according to some studies and are observed in almost all patients with Idiopathic Intracranial Hypertension (IIH), which is characterized by signs and symptoms that include, in addition to headache, nausea, vomiting, diplopia, decreased visual acuity, pulsatile tinnitus, back and neck pain, among other possible manifestations. However, the clinical presentation is highly variable, which can delay diagnosis. Case report A.T.F, female, 33 years old, BMI 40.17 kg / m², with grade 3 obesity, caucasian, single, with Down Syndrome. Presents a history of post-surgical hypothyroidism, whose thyroidectomy was performed 10 years ago, due to nodular goiter. This patient presented subacute nausea, visual turbidity, diarrhea and pulsatile holocranial headache, which worsened in the horizontal position and presented slight relief in the orthostatic position. Conclusion The conduct of Fahrs Syndrome, in this case, was focused on the treatment of hypoparathyroidism and which consists of correcting metabolism disorders of phosphorus and calcium, which naturally resulted in clinical and radiological improvement, however, without definitive resolution of the condition.Downloads
Os dados de download ainda não estão disponíveis.
Downloads
Publicado
2020-09-30
Edição
Seção
Relato de caso
Licença
Copyright (c) 2020 Headache Medicine

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Como Citar
1.
Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report. Headache Med [Internet]. 30º de setembro de 2020 [citado 22º de janeiro de 2026];11(3):68-71. Disponível em: https://headachemedicine.com.br/hm/article/view/413






